Literature DB >> 25039052

Growth inhibition of Mycobacterium smegmatis by mycobacteriophage-derived enzymes.

Navdeep Grover1, Elena E Paskaleva1, Krunal K Mehta1, Jonathan S Dordick2, Ravi S Kane3.   

Abstract

We report the ability of mycobacteriophage-derived endolysins to inhibit the growth of Mycobacterium smegmatis. We expressed and purified LysB from mycobacteriophage Bxz2 and compared its activity with that of a previously reported LysB from mycobacteriophage Ms6. The esterase activity of Bxz2 LysB with pNP esters was 10-fold higher than that of the previously reported LysB but its lipolytic activity was significantly lower. The presence of surfactant - Tween 80 or Triton X-100 - significantly increased the activity of LysB. Characterization of LysB-treated M. smegmatis cells and LysB-treated purified cell wall by mass spectroscopy confirmed the hydrolytic activity of the enzyme. Both enzymes were equally effective in inhibiting the growth of M. smegmatis, demonstrating their potential as bacteriostatic agents.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bactericidal; LysB; Mycobacteriophage; Mycobacterium smegmatis; Phage derived lysins; Tuberculosis

Mesh:

Substances:

Year:  2014        PMID: 25039052     DOI: 10.1016/j.enzmictec.2014.04.018

Source DB:  PubMed          Journal:  Enzyme Microb Technol        ISSN: 0141-0229            Impact factor:   3.493


  12 in total

1.  Isolation and complete genome sequence of a novel virulent mycobacteriophage, CASbig.

Authors:  Tieshan Teng; Junping Yu; Hang Yang; Hongping Wei
Journal:  Virol Sin       Date:  2015-02       Impact factor: 4.327

2.  Newly identified bacteriolytic enzymes that target a wide range of clinical isolates of Clostridium difficile.

Authors:  Krunal K Mehta; Elena E Paskaleva; Xia Wu; Navdeep Grover; Ruchir V Mundra; Kevin Chen; Yongrong Zhang; Zhiyong Yang; Hanping Feng; Jonathan S Dordick; Ravi S Kane
Journal:  Biotechnol Bioeng       Date:  2016-06-20       Impact factor: 4.530

3.  A Surfactant-Induced Functional Modulation of a Global Virulence Regulator from Staphylococcus aureus.

Authors:  Sukhendu Mandal; Avisek Mahapa; Anindya Biswas; Biswanath Jana; Soumitra Polley; Keya Sau; Subrata Sau
Journal:  PLoS One       Date:  2016-03-18       Impact factor: 3.240

4.  Mycobacteriophage SWU1 gp39 can potentiate multiple antibiotics against Mycobacterium via altering the cell wall permeability.

Authors:  Qiming Li; Mingliang Zhou; Xiangyu Fan; Jianlong Yan; Weimin Li; Jianping Xie
Journal:  Sci Rep       Date:  2016-06-28       Impact factor: 4.379

5.  Therapeutic Application of Phage Capsule Depolymerases against K1, K5, and K30 Capsulated E. coli in Mice.

Authors:  Han Lin; Matthew L Paff; Ian J Molineux; James J Bull
Journal:  Front Microbiol       Date:  2017-11-16       Impact factor: 5.640

6.  Phage therapy as a renewed therapeutic approach to mycobacterial infections: a comprehensive review.

Authors:  Taher Azimi; Mehrdad Mosadegh; Mohammad Javad Nasiri; Sahar Sabour; Samira Karimaei; Ahmad Nasser
Journal:  Infect Drug Resist       Date:  2019-09-17       Impact factor: 4.003

7.  Exploration of Synergistic Action of Cell Wall-Degrading Enzymes against Mycobacterium tuberculosis.

Authors:  Loes van Schie; Katlyn Borgers; Gitte Michielsen; Evelyn Plets; Marnik Vuylsteke; Petra Tiels; Nele Festjens; Nico Callewaert
Journal:  Antimicrob Agents Chemother       Date:  2021-07-19       Impact factor: 5.191

Review 8.  Phage Lysins for Fighting Bacterial Respiratory Infections: A New Generation of Antimicrobials.

Authors:  Roberto Vázquez; Ernesto García; Pedro García
Journal:  Front Immunol       Date:  2018-10-16       Impact factor: 7.561

9.  Comparative Structural Analysis of Different Mycobacteriophage-Derived Mycolylarabinogalactan Esterases (Lysin B).

Authors:  Ahmed H Korany; Adel Abouhmad; Walid Bakeer; Tamer Essam; Magdy A Amin; Rajni Hatti-Kaul; Tarek Dishisha
Journal:  Biomolecules       Date:  2019-12-27

Review 10.  Looking beyond Typical Treatments for Atypical Mycobacteria.

Authors:  Clara M Bento; Maria Salomé Gomes; Tânia Silva
Journal:  Antibiotics (Basel)       Date:  2020-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.